Cellular model systems to study cardiovascular injury from chemotherapy.
Cellular model systems to study cardiovascular injury from chemotherapy.
复制标题
DOI:
10.1007/s11239-020-02299-x
复制
发表时间:
2021-05
影响因子:
4
通讯作者:
Burridge, Paul W.
中科院分区:
文献类型:
--
作者:
Fonoudi, Hananeh;Burridge, Paul W.
关键词:
In spite of all the efforts for generating efficient pharmacological treatment options for cancer patients, the unwanted side effect of these substances on the cardiovascular system is becoming a major issue for cancer survivors. The fast pacing oncology field necessitate the quest for more accurate and reliable preclinical screenings. hiPSCs derived cardiomyocytes, endothelial and vascular smooth muscle cells provide unlimited source of physiologically relevant cells that could be used in the screening platforms. Cells derived from hiPSCs can measure drug induced alterations to different aspect of the heart including electrophysiology, contractility and structure. In this review, we will give an overview of the different in vivo and in vitro preclinical drug safety screenings. In following sections, we will focus on hiPSCs-derived cardiomyocytes, endothelial and vascular smooth muscle cells and present the current knowledge of the application of these cells in unicellular cardiotoxicity assays. In the final part, we will focus on cardiac organoids as multi cell type platform and their role in cardiotoxicity screening of the chemotherapeutic drugs.
登录
查看更多内容
影响因子:
4.6
作者:
Archer CR;Sargeant R;Basak J;Pilling J;Barnes JR;Pointon A
通讯作者:
Pointon A
影响因子:
7.7
作者:
Knowles DA;Burrows CK;Blischak JD;Patterson KM;Serie DJ;Norton N;Ober C;Pritchard JK;Gilad Y
通讯作者:
Gilad Y
影响因子:
28.1
作者:
Richards, Dylan J.;Li, Yang;Mei, Ying
通讯作者:
Mei, Ying
DOI:
10.1164/rccm.201606-1200oc
发表时间:
2017-04-01
影响因子:
24.7
作者:
Sa, Silin;Gu, Mingxia;Rabinovitch, Marlene
通讯作者:
Rabinovitch, Marlene
影响因子:
20.1
作者:
Mercola M;Colas A;Willems E
通讯作者:
Willems E